Professor Wang Tso-ren, director of NTUH's Division of Clinical Genetics, was involved in the planning of the screening program in its early years. He says the incidence of CHT in Taiwan is now known to be one in 3,000 live births, that of PKU one in 40,000, and that of galactosemia one in 200,000.
早期參與篩檢計畫的台大醫學遺傳學教授王作仁指出，以先天性甲狀腺低能症為例，目前已知台灣地區發生率為三千分之一，苯酮尿症的發生率為四萬分之一，半乳糖血症是二十萬分之一。